ribavirin has been researched along with Hashimoto Disease in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CC; Chang, YS; Chen, JH; Chen, SC; Chou, SM; Hsu, HC; Kuo, TT; Lin, TM; Shen, YC; Yeh, HJ | 1 |
| Arama, V; Popescu, C; Popescu, GA | 1 |
| Gong, WJ; Ma, XH; Sun, YX; Teng, ZL; Zhang, SQ | 1 |
| Halota, W; Junik, R; Kozielewicz, D | 1 |
| Egawa, H; Hata, K; Hori, T; Nguyen, JH; Nishikiori, M; Ogawa, K; Ogura, Y; Oike, F; Takada, Y; Uemoto, S | 1 |
| Archimandritis, AJ; Giannaris, M; Koskinas, J; Malaktari, S; Papakostas, N; Savvas, SP | 1 |
| Ishibashi, S; Nagasaka, S; Okada, K; Okada, N; Osuga, J; Sato, S; Sugano, K; Yagyu, H; Yamashita, Y | 1 |
| Halota, W; Kozielewicz, D | 1 |
| Deutsch, M; Hadziyannis, S; Koskinas, J; Mailis, A; Tolis, G; Tzannos, K; Vassilopoulos, D | 1 |
| Bilusic, M; Hrstic, I; Huic, D; Vucelic, B | 1 |
| Battegay, E; Mettler, J; Zimmerli, L | 1 |
11 other study(ies) available for ribavirin and Hashimoto Disease
| Article | Year |
|---|---|
Association of interferon-based therapy with risk of autoimmune diseases in patients with chronic hepatitis C virus infection: A population-based Taiwanese cohort study.
Topics: Cohort Studies; Graves Disease; Hashimoto Disease; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Retrospective Studies; Ribavirin; Risk Factors | 2022 |
Type 1 diabetes mellitus with dual autoimmune mechanism related to pegylated interferon and ribavirin treatment for chronic HCV hepatitis.
Topics: Antiviral Agents; Autoantibodies; Autoimmune Diseases; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Hashimoto Disease; Hepatitis C, Chronic; Humans; Insulin Resistance; Interferon-alpha; Islets of Langerhans; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Vitiligo; Young Adult | 2013 |
[Clinical observation of Hashimoto thyroiditis in patients with chronic hepatitis C undergoing pegylated-interferon alpha-2a and ribavirin combination therapy].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Young Adult | 2013 |
[Thyrotoxicosis induced by interferonotherapy of chronic hepatitis C in a woman with Hashimoto's thyroiditis].
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin; Thyrotoxicosis | 2014 |
Hashimoto's encephalopathy after interferon therapy for hepatitis C virus in adult liver transplant recipient accompanied by post-transplant lymphoproliferative disorder related to Epstein-Barr virus infection.
Topics: Antiviral Agents; Brain Diseases; Drug Therapy, Combination; Encephalitis; Epstein-Barr Virus Infections; Female; Hashimoto Disease; Hepacivirus; Hepatitis C; Humans; Interferons; Liver Transplantation; Lymphoproliferative Disorders; Middle Aged; Polyethylene Glycols; Ribavirin | 2010 |
Interferon alpha-induced hashimoto thyroiditis followed by transient graves disease in a patient with chronic HCV infection.
Topics: Adult; Antiviral Agents; Autoantibodies; Autoantigens; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Graves Disease; Hashimoto Disease; Hepatitis C, Chronic; Humans; Hypothyroidism; Interferon alpha-2; Interferon-alpha; Iodide Peroxidase; Iron-Binding Proteins; Male; Polyethylene Glycols; Receptors, Thyrotropin; Recombinant Proteins; Ribavirin; Th1 Cells; Th2 Cells | 2010 |
Pegylated interferon-α2b and ribavirin combination therapy induces Hashitoxicosis followed by type 1 diabetes mellitus.
Topics: Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Thyrotoxicosis | 2012 |
Interferon-induced thyroiditis during treatment of chronic hepatitis C.
Topics: Age Factors; Algorithms; Antithyroid Agents; Antiviral Agents; Autoantibodies; Diagnosis, Differential; Drug Interactions; Female; Graves Disease; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Ribavirin; Risk Factors; Sex Factors; Thyroid Gland; Thyroiditis | 2012 |
Hashimoto encephalopathy with pegylated interferon alfa-2b and ribavirin.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Neurotoxicity Syndromes; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2005 |
Autoimmune disorders during interferon therapy in a patient with chronic hepatitis C infection: how many of them can be observed in a single patient?
Topics: Anemia, Hemolytic, Autoimmune; Antiviral Agents; Disease Progression; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin | 2006 |
[Chronic fatigue. IV--Assessment of a 40-year-old patient].
Topics: Adult; Anemia, Iron-Deficiency; Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Fatigue Syndrome, Chronic; Hashimoto Disease; Hepatitis C, Chronic; Humans; Interferons; Liver Cirrhosis; Male; Methadone; Narcotics; Opioid-Related Disorders; Ribavirin; Thyroid Function Tests | 2007 |